Monique is responsible for the Corporate Communications, IR and Patient Advocacy functions at Anaptys. Previously, Monique was SVP of Corporate Communications at AVROBIO, where she led Global Communications and served as a member of AVROBIO’s senior leadership team. Prior to AVROBIO, she was previously vice president, corporate communications at Spark Therapeutics, where she led the communications efforts for the regulatory approval and launch of the first gene therapy for a genetic disease in the U.S. She joined Spark from Biogen, where she led the U.S. public affairs group, launching four new medicines in two years. Before Biogen, she worked in U.S. and global leadership positions at Ogilvy PR and MSLGroup. Monique is a proud member of CHIEF. She has an B.A. from Bowdoin College, Brunswick, Maine and completed the General Management Program at Harvard Business School.